Psychiatric conditions. Depression
Conditions
Interventions
Intervention 1: In the intervention group, the athletes were received 5 gram Creatine Monohydrate (from Karen pharmaceutical company) in 7 capsules, administered orally, daily for 6 weeks. Interventio
Treatment - Drugs
Placebo
In the intervention group, the athletes were received 5 gram Creatine Monohydrate (from Karen pharmaceutical company) in 7 capsules, administered orally, daily for 6 weeks.
The placebo group received wheat flour capsule (7 capsules daily) for the same time (6 weeks) and the same appearance (Creatine capsule) in intervention group.
Sponsors
Vice chancellor for research of Iran university of medical sciences
Eligibility
Sex/Gender
Male
Age
16 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: age between 16-60, male gender; regular daily physical exercise; not having history of allergy to Creatine; not having history of medical disease such as heart disease, renal disorder, thyroid disease or cancer; not having history of psychiatric drug consumption or OTC usage or drug and alcohol abuse during past 3 months; not having history of axis 1 psychiatric disorders. Exclusion criteria: allergy to Creatine; any medical complication during the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score of mood. Timepoint: Before the intervention, 3 weeks after begining of intervention, 6 weeks after begining of intervention. Method of measurement: Beck depression scale.;The score of affect. Timepoint: Before the intervention, 3 weeks after begining of intervention, 6 weeks after begining of intervention. Method of measurement: PANAS questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehrdad Eftekhar
Iran university of medical sciences
Outcome results
None listed